Program to Prevent Lymphedema After Breast Cancer Surgery

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Recruiting Phase 3 Interventional Study
Lymphedema Lymphedema Arm Lymphedema of Upper Arm Breast Cancer Breast Carcinoma Female Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Female
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
285 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Other
Who this trial is looking for

This trial is looking for women with breast cancer who are having surgery that may affect lymph fluid in their arms. Participants will take part in a program to help reduce the risk of lymphedema.

Are You a Good Fit for This Trial?
Rules you out Impaired decision-making capacity

You may be able to join if

  • I am female
  • I have been diagnosed with breast cancer
  • I am between 18 and 75 years old
  • I have agreed to have surgery that may involve axillary lymph node dissection

You may not be able to join if

  • I am male
  • I do not speak English
  • I cannot fit into the study garment
  • I have had cancer return in my armpit area
  • I have a history of axillary lymph node dissection
  • I need to have surgery on both sides for breast cancer
  • I am only having sentinel lymph node biopsy
  • I have a known severe allergy to ICG dye

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Female sex * Diagnosis of breast cancer * Ages 18 to 75 years * Consented for unilateral ALND or for unilateral SLNB with possible ALND Exclusion Criteria: * Male sex * Does not speak English * Does not fit into study garment * Axillary recurrence * History of ALND * Require…
Contacts

Michelle Coriddi, MD

646-608-8042

coriddim@mskcc.org

CONTACT

Babak Mahrara, MD

646-608-8085

mehrarab@MSKCC.ORG

CONTACT